• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Molecular mechanisms regulating CD19, CD20 and CD22 gene expression.

作者信息

Kehrl J H, Riva A, Wilson G L, Thévenin C

机构信息

Section of B Cell Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.

出版信息

Immunol Today. 1994 Sep;15(9):432-6. doi: 10.1016/0167-5699(94)90273-9.

DOI:10.1016/0167-5699(94)90273-9
PMID:7524520
Abstract

The CD19, CD20 and CD22 genes encode transmembrane proteins that are of vital importance to B-cell function. Similar to the immunoglobulin (Ig) genes, they are expressed in a lineage-specific and developmentally regulated manner. Here, John Kehrl and colleagues describe how an understanding of the transcriptional regulation of the CD19, CD20 and CD22 genes is leading to valuable insights into some of the important molecular events that occur in B-cell development and differentiation.

摘要

相似文献

1
Molecular mechanisms regulating CD19, CD20 and CD22 gene expression.
Immunol Today. 1994 Sep;15(9):432-6. doi: 10.1016/0167-5699(94)90273-9.
2
PU.1 protein expression has a positive linear association with protein expression of germinal centre B cell genes including BCL-6, CD10, CD20 and CD22: identification of PU.1 putative binding sites in the BCL-6 promotor.PU.1蛋白表达与生发中心B细胞基因(包括BCL-6、CD10、CD20和CD22)的蛋白表达呈正线性关联:在BCL-6启动子中鉴定PU.1假定结合位点。
J Pathol. 2005 Jul;206(3):312-9. doi: 10.1002/path.1777.
3
Differential expression of the B cell-restricted molecule CD22 on neonatal B lymphocytes depending upon antigen stimulation.
Eur J Immunol. 2000 Feb;30(2):550-9. doi: 10.1002/1521-4141(200002)30:2<550::AID-IMMU550>3.0.CO;2-X.
4
Epratuzumab, a humanized monoclonal antibody targeting CD22: characterization of in vitro properties.依帕珠单抗,一种靶向CD22的人源化单克隆抗体:体外特性表征
Clin Cancer Res. 2003 Sep 1;9(10 Pt 2):3982S-90S.
5
Regulation of lymphocyte activation by the cell-surface molecule CD22.细胞表面分子CD22对淋巴细胞激活的调控。
Immunol Today. 1994 Sep;15(9):442-9. doi: 10.1016/0167-5699(94)90275-5.
6
Characterization of the expression and gene promoter of CD22 in murine B cells.小鼠B细胞中CD22的表达及基因启动子的特征分析
Eur J Immunol. 1996 Dec;26(12):3170-8. doi: 10.1002/eji.1830261250.
7
Genomic structure and chromosomal mapping of the human CD22 gene.人类CD22基因的基因组结构与染色体定位
J Immunol. 1993 Jun 1;150(11):5013-24.
8
Ig domains 1 and 2 of murine CD22 constitute the ligand-binding domain and bind multiple sialylated ligands expressed on B and T cells.小鼠CD22的免疫球蛋白结构域1和2构成配体结合结构域,并与B细胞和T细胞上表达的多种唾液酸化配体结合。
J Immunol. 1995 Oct 1;155(7):3368-76.
9
CD22 regulates thymus-independent responses and the lifespan of B cells.CD22调节非胸腺依赖性反应和B细胞的寿命。
Nature. 1996;384(6610):634-7. doi: 10.1038/384634a0.
10
CD22 regulates early B cell development in BOB.1/OBF.1-deficient mice.CD22调节BOB.1/OBF.1缺陷小鼠的早期B细胞发育。
Eur J Immunol. 2002 Sep;32(9):2481-9. doi: 10.1002/1521-4141(200209)32:9<2481::AID-IMMU2481>3.0.CO;2-C.

引用本文的文献

1
An overview on in-vivo generation of CAR-T cells using CRISPR-loaded functionalized nanocarriers for treating B-cell lineage acute lymphoblastic leukemia.使用负载CRISPR的功能化纳米载体在体内生成CAR-T细胞用于治疗B细胞系急性淋巴细胞白血病的综述。
Mol Biol Rep. 2025 Jun 14;52(1):596. doi: 10.1007/s11033-025-10674-1.
2
Phase 1b/2a Study Assessing the Safety and Efficacy of Felzartamab in Anti-Phospholipase A2 Receptor Autoantibody-Positive Primary Membranous Nephropathy.评估非扎妥单抗在抗磷脂酶A2受体自身抗体阳性原发性膜性肾病中的安全性和有效性的1b/2a期研究
Kidney Int Rep. 2024 Jun 20;9(9):2635-2647. doi: 10.1016/j.ekir.2024.06.018. eCollection 2024 Sep.
3
The Evolving Landscape of Flowcytometric Minimal Residual Disease Monitoring in B-Cell Precursor Acute Lymphoblastic Leukemia.
流式细胞术微小残留病监测在 B 细胞前体急性淋巴细胞白血病中的演变。
Int J Mol Sci. 2024 Apr 30;25(9):4881. doi: 10.3390/ijms25094881.
4
BAFF induces CXCR5 expression during B cell differentiation in bone marrow.在骨髓中B细胞分化过程中,B细胞活化因子诱导趋化因子受体5表达。
Biochem Biophys Rep. 2023 Mar 7;34:101451. doi: 10.1016/j.bbrep.2023.101451. eCollection 2023 Jul.
5
Lupus Nephritis: Current Perspectives and Moving Forward.狼疮性肾炎:当前观点与未来展望
J Inflamm Res. 2022 Dec 2;15:6533-6552. doi: 10.2147/JIR.S363722. eCollection 2022.
6
A Deep Insight Into CAR-T Cell Therapy in Non-Hodgkin Lymphoma: Application, Opportunities, and Future Directions.深入了解 CAR-T 细胞疗法在非霍奇金淋巴瘤中的应用、机遇和未来方向。
Front Immunol. 2021 Jun 23;12:681984. doi: 10.3389/fimmu.2021.681984. eCollection 2021.
7
Sequential anti-CD19, 22, and 20 autologous chimeric antigen receptor T-cell (CAR-T) treatments of a child with relapsed refractory Burkitt lymphoma: a case report and literature review.序贯抗 CD19、22 和 20 自体嵌合抗原受体 T 细胞(CAR-T)治疗复发难治性伯基特淋巴瘤患儿:病例报告及文献复习。
J Cancer Res Clin Oncol. 2020 Jun;146(6):1575-1582. doi: 10.1007/s00432-020-03198-7. Epub 2020 Mar 28.
8
Targeting B Cells and Plasma Cells in Autoimmune Diseases.靶向自身免疫性疾病中的 B 细胞和浆细胞。
Front Immunol. 2018 Apr 23;9:835. doi: 10.3389/fimmu.2018.00835. eCollection 2018.
9
Therapeutic Antibodies: What Have We Learnt from Targeting CD20 and Where Are We Going?治疗性抗体:我们从靶向CD20中学到了什么,又将何去何从?
Front Immunol. 2017 Oct 4;8:1245. doi: 10.3389/fimmu.2017.01245. eCollection 2017.
10
Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups.表达和甲基化模式将腔面A型乳腺肿瘤分为不同的预后亚组。
Breast Cancer Res. 2016 Jul 7;18(1):74. doi: 10.1186/s13058-016-0724-2.